2nd Nuclear Receptors Conference is organized by Fusion Conferences Ltd and will be held from Feb 24 - 27, 2020 at Melia Nassau Beach Hotel, Nassau, New Providence, Bahamas.
Scientists and Clinician Scientists at a range of levels from postdoctoral and up: Principal Investigators, Junior Team Leaders, Research Fellows. Ambitious postgraduate students in the field will also be encouraged to attend.
Relevant specialties are wide-ranging, reflecting the importance of nuclear receptors in many aspects of health and disease. These include Endocrinology, Oncology, Paediatrics, Urology, Gynaecology, Obstetric Medicine, Neuroscience, Cardiology.
This meeting will address the new roles and novel crosstalk mechanisms that are emerging for many of the 48 human nuclear receptors, in health and disease. For example, it has long been known that the estrogen receptor drives progression of breast cancer, and patients with estrogen receptor-positive disease are treated using antiestrogens or aromatase inhibitors to inhibit estrogen signalling. Now however, it is apparent that the androgen receptor can in some cases drive breast cancer progression and is a therapeutic target, resulting in clinical trials for androgen receptor-targeting therapies in advanced breast cancer. The androgen receptor, itself long the main therapeutic target in prostate cancer, is emerging as a key player in metabolic disease, while conversely other nuclear receptor including the glucocorticoid receptor and several orphan nuclear receptors are implicated in prostate cancer progression. Meanwhile, given the impact of many nuclear receptors on the central nervous system, it is unsurprising that they are being explored in the context of neurological disorders and depression. Thus there is wide scope for re-purposing of licensed drugs and development of new NR-targeting therapies for a host of conditions and diseases.
This unique meeting will bring together many of the leading figures in nuclear receptor research from across the globe, to discuss emerging roles and their implications for health and disease - and both human and drug development - in an intimate meeting that will generate meaningful idea exchange and interaction that will help to further shape this influential field.
• Further emerging roles for nuclear receptors in cancer
• Structural insights into nuclear receptor function and crosstalk
• Nuclear receptors’ role in epigenetic regulation and non coding RNA
• Nuclear receptors and DNA damage
• Nuclear receptors and cell cycle
• Nuclear receptors in metabolism/metabolic disease
• Nuclear receptors in the CNS
Additional details will be posted as soon as they are available.
|Contact No. :||+44 (0) 1638 724137
December 20, 2019
|Registration Type||Last Date||Price|
|Academic Full Price||23 Feb,2020||USD 1935.00|
|Industry Full Price||23 Feb,2020||USD 1935.00|
|Student Full Price||23 Feb,2020||USD 1646.00|
|Registration Type||End Date||Price|
|Academic Early Fee||09 Sep,2019||USD 1835.00|
|Industry Early Fee||09 Sep,2019||USD 1835.00|
|Student Early Fee||09 Sep,2019||USD 1546.00|
Melia Nassau Beach Hotel
Nassau, New Providence, Bahamas
Melia Nassau Beach All Inclusive,
Nassau, W Bay St,
Nassau, New Providence, Bahamas ,